DocDollars

Novocure Inc.

NH · United States · Reporting entity ID 100000005413

Total reported 2019–2025
$32.8M
#221 of 2,960 reporting companies — 0% of all reported industry payments
$7.43M in general payments across 21,684 records, plus $25.4M in research funding across 4,010 records.

How it breaks down

General payments $7,427,888
Research funding $25,355,872

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Novocure Inc. reported $32.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #221 of 2,960 reporting companies. 77% of that was research funding and 23% general payments such as consulting, speaking, food and travel. 21,684 general payment records and 4,010 research records were filed.

Common questions about Novocure Inc.

How much has Novocure Inc. paid US doctors?

Novocure Inc. reported $32,783,760 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $7,427,888 in general payments, $25,355,872 in research funding.

How does Novocure Inc. rank among drug and device companies?

It ranks #221 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Novocure Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.